If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.05    0.00 (0.00%)
Bid:
1.90
Ask:
2.20
Spread: 0.30 (15.789%)
Market Cap: £2.81m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

Trading Update

4 Oct 2017 07:00

RNS Number : 6518S
Image Scan Holdings PLC
04 October 2017
 



4 October 2017

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

 

 

IMAGE SCAN HOLDINGS PLC

 

("Image Scan" or the "Company")

 

Trading Update

 

Image Scan (AIM:IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets is pleased to provide a further positive trading update for the year to 30 September 2017 ("FY17"). This follows the previous update issued on 29 August which pointed to sales of approximately £4.5m and profit before tax of £250k.

 

A multi-unit portable X-ray order was placed earlier than expected and the Company accelerated the completion of units intended for delivery later in the year for another customer to satisfy this new order. Also, factory acceptance on two industrial x-ray inspection machines was completed earlier than expected. The combined effect of these changes means that the Company generated sales of approximately £5.0m and subject to any audit adjustments, expects to report profit before tax of approximately £450k in FY17. The order book at 30 September 2017 was £2.1m. Delivery times on some orders are still subject to negotiation and could exceed 12 months in some cases.

 

Bill Mawer, Chairman and CEO of Image Scan, said: "September has been an exceptionally busy month for the Company and the response of our staff to new opportunities has been very impressive. I am also particularly pleased by the strength of the orderbook with which we start the new financial year. Demand for our new systems remains strong."

 

The Company will issue a more detailed pre-close trading update at the end of October ahead of its preliminary results for FY17.

 

-ENDS-

 

For further information, please contact:

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

William Mawer, Chairman

Sarah Atwell-King, Company Secretary

ir@ish.co.uk

 

Cantor Fitzgerald Europe Tel: +44 (0) 207 894 7000

Rick Thompson / David Foreman (Corporate Finance)

Alex Pollen / Mark Westcott (Sales)

 

About Image Scan Holdings plc

Image Scan Holdings plc (AIM: IGE) is focused on the development and commercialisation of market leading real-time X-ray solutions for use in the global Security and Industrial inspection markets. The Company's Security portfolio includes the ThreatScan® range of portable bomb and suspect package detection systems; the Axis range of baggage inspection systems; and SVXi, a small vehicle inspection system. The Industrial inspection solutions include the MDXi product range, cabinet X-ray systems for laboratories and production lines. The Company was founded in 1996 and joined AIM in 2002.

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFSLSILFWSEIS
Date   Source Headline
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSInterim Report
28th Apr 20217:00 amRNSNew order
23rd Feb 202111:18 amRNSResult of AGM
22nd Feb 20217:00 amRNSTrading Statement
15th Feb 202111:33 amRNSMello presentation
21st Jan 20217:00 amRNSContract win
6th Jan 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20207:00 amRNSFinal Results
28th Oct 20207:00 amRNSTrading Update
12th Oct 20207:00 amRNSLaunch of innovative new security system
1st Sep 20207:00 amRNSTrading Update
13th Jul 20207:00 amRNSPartnership Agreement
15th Jun 202012:05 pmRNSHolding(s) in Company
15th Jun 20207:00 amRNSChange of Adviser
29th Apr 20207:00 amRNSInterim Results
25th Feb 20203:00 pmRNSResult of AGM
6th Feb 20207:00 amRNSTrading Update
21st Jan 20207:00 amRNSPosting of Annual Report and Notice of AGM
3rd Dec 20197:00 amRNSPreliminary Results
21st Oct 20197:00 amRNSPre-Close Trading Update
18th Sep 20197:00 amRNSContract Win and Further Trading Update
26th Jun 20197:00 amRNSTrading Update
24th May 20191:35 pmRNSHolding(s) in Company
25th Apr 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.